- Location
peripheral artery disease
"-
Philips to Complete The Acquisition of Volcano for $1.2 Billion
Dec 19, 2014Royal Philips NV (PHG) plans to buy medical-imaging company Volcano Corp. (VOL) for $1.2 billion, in one of Philips’ largest acquisitions in years, according to a Bloomberg report. The purchase of San Diego–based Volcano will ...
-
Atheromed Gets Approval From FDA for Phoenix Atherectomy System
Feb 7, 2014AtheroMed has obtained marketing approval from the US Food and Drug Administration (FDA) for its Phoenix atherectomy system for treating peripheral artery disease (PAD). Phoenix atherectomy system is a peripheral atherectomy catheter ...
Tags: FDA, pPAD, debulked material, Archimedes Screw
-
Older Women with Heart Disease Might Be at Increased Risk for Dementia
Dec 25, 2013Older women with heart disease might be at increased risk for dementia, according to a new study. Researchers followed nearly 6,500 U.S. women, aged 65 to 79, who had healthy brain function when the study started. Those with heart disease ...
Tags: older women health, heart disease, dementia
-
Initiation of TOBA-BTK Study Has Been Declared by Intact Vascular
Dec 19, 2013Intact Vascular, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced the start of enrollment in the Tack Optimized Balloon Angioplasty Below the Knee (TOBA-BTK) study. This multi-center ...
Tags: Intact Vascular, medical devices
-
AngioScore Presented Results From FIH That Angiosculpt Ptca Scoring Balloon Catheter
Nov 14, 2013US-based AngioScore has presented six-month clinical and quantitative coronary angiography results from the first-in-human (FIH) clinical trial of its drug-coated AngioSculpt PTCA scoring balloon catheter at the Transcatheter Cardiovascular ...
Tags: AngioScore, Balloon Catheter
-
IMH Has Approved Pluristem Therapeutics' Request to Start a Phase II Trial
Oct 9, 2013The Israeli Ministry of Health (IMH) has approved Pluristem Therapeutics’ request to start a Phase II trial using its PLacental eXpanded (PLX) cells in the treatment of intermittent claudication (IC). IC is a subset of peripheral ...
Tags: clinical study, Medicine
-
Avinger Designed to Remove Blockage While Avoiding Disruption of Arterial Wall Structures
Aug 30, 2013Avinger, a manufacturer of multifunctional catheters, has received CE Mark approval for Pantheris, a lumectomy catheter designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This lumivascular ...
-
Abbott Completed Its Acquisition of Idev Technologies
Aug 26, 2013Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
-
Medtronic Submitted Its PMA for The IN.PACT Admiral Drug-Eluting Balloon
Aug 19, 2013Medtronic has submitted its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon designed to treat atherosclerotic lesions in the superficial femoral artery ...
Tags: Medtronic, Admiral Drug-Eluting
-
Abbott Agreed to Buy a Stent Maker and Surgery Systems Manufacturer in Two Separate Deals
Jul 17, 2013US-based Abbott has agreed to buy a stent maker and an eye surgery systems manufacturer in two separate deals, worth about $710m, as part of its strategy to expand its medical device business. Illinois-based Abbott agreed to purchase ...
Tags: Stent Maker, Ophthalmic Device
-
Balloon Catheters Are Scored by AngioScore PTA
Jan 29, 2013AngioScore, a US based endovascular company, has launched new 100 mm length AngioSculpt PTA Scoring Balloon Catheters to treat complex lesions in patients with peripheral artery disease (PAD) below the knee (BTK) including critical limb ...
Tags: AngioScore, PTA Scoring Balloon Catheters, peripheral artery disease, PAD
-
Patient Enrollment for IN.PACT Admiral Drug-Eluting Balloon Study Is Completed by Medtroni
Jan 28, 2013Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
-
Final Results of Definitive LE Trial Has Been Reported by Covidien
Dec 18, 2012Covidien has reported final 12-month results from Determination of Effectiveness of SilverHawk / TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities (DEFINITIVE LE ) trial. The ...
Tags: Covidien, 12-month results, DEFINITIVE LE trial, prospective study
-
Abbott Has Obtained FDA Approval for Its Omnilink Elite Vascular Stent System
Dec 18, 2012Abbott has obtained the US Food and Drug Administration (FDA) approval for its Omnilink Elite Vascular Balloon-Expandable Stent system, designed as a treatment for atherosclerotic iliac artery lesions with reference vessel diameters of ≥ ...
Tags: Abbott, FDA, approval, Omnilink Elite stent, study, Omnilink Elite
-
Avinger Reports That It Will Present CONNECT II Clinical Trial Results at VIVA Conference
Dec 17, 2012Avinger has reported that it will present the CONNECT II clinical trial results at the Vascular Interventional Advances (VIVA) conference being held in Las Vegas, Nevada, US, between 9-12 October 2012. The prospective, multi-center, ...
